Printer Friendly

LabCorp Acquires Bode Technology.


US-based diagnostic technologies provider Laboratory Corp. of America Holdings (LabCorp) (NYSE: LH) said it has closed its acquisition of Bode Technology Group, Inc. from SolutionPoint International, Inc.

As a wholly-owned subsidiary of LabCorp, Bode Technology and its division Chromosomal Labs will continue to provide specialised forensic DNA analysis, proprietary DNA collection products, and relationship testing to an international market.

The unit will work in combination with LabCorp's US and UK-based DNA Identity and Cellmark Forensics businesses, part of LabCorp's Specialty Testing Group.

Under the new combined businesses, Cellmark Forensics and Bode Technology will provide DNA testing services to federal and state governments, law enforcement agencies, crime laboratories, disaster management organizations, and various consumer markets throughout the United States and around the world.

Laboratory Corp. of America Holdings is engaged in commercialising new diagnostic technologies, with a focus on genomic testing.

The company posted revenues of USD 5.8bn in 2013, and has more than 34,000 employees worldwide.

Country: USA

Sector: Healthcare

Target: Bode Technology Group, Inc

Buyer: Laboratory Corp. of America Holdings

Deal size in USD:

Type: Corporate acquisition


Status: Closed

Buyer advisor: , ,


COPYRIGHT 2014 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2014 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M & A Navigator
Date:Dec 5, 2014
Previous Article:KSR International Completes Integration of Its Strategic acquisition Ahead of Schedule.
Next Article:Land Securities Ups Stake in Kent Shopping Centre.

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters